Results 1 to 10 of about 312,725 (94)

4-Year Follow-Up After Transatrial Transcatheter Tricuspid Valve Replacement With the LuX-Valve

Journal of Cardiovascular Development and Disease, 2022
Tricuspid regurgitation (TR) has become one of the most common valve diseases. Patients with severe TR are often at high surgical mortality risk. Transcatheter tricuspid valve interventions have emerged as a promising alternative to open-heart surgery.
Lin Han, Zhiyun Xu, Fan Qiao
exaly   +6 more sources

[Efficacy of the Transcatheter Tricuspid Valve Replacement for Patients With Severe Tricuspid Regurgitation: Lux-Valve Versus Lux-Valve Plus].

Zhejiang Da Xue Xue Bao Yi Xue Ban = Journal of Zhejiang University Medical Sciences
To compare the efficacy of transcatheter tricuspid valve replacement (TTVR) using Lux-Valve and Lux-Valve Plus in patients with severe tricuspid regurgitation.A total of 28 consecutive patients with severe tricuspid regurgitation who underwent TTVR with Lux-Valve (n=14) or Lux-Valve Plus (n=14) in the First Affiliated Hospital of the Air Force Medical ...
Liwen Liu, Xin Meng, Guomeng Jiang
exaly   +7 more sources

Comparison of Clinical and Echocardiographic Outcomes Between Mini-Thoracotomy Transatrial LuX-Valve Transcatheter and Surgical Tricuspid Valve Replacement

Frontiers in Cardiovascular Medicine
Background and aimsTranscatheter tricuspid valve replacement (TTVR) has recently emerged as a novel therapeutic approach for managing severe tricuspid regurgitation (TR). However, surgical tricuspid valve replacement (STVR) continues to be the predominant treatment modality. There are limited comparative data on both procedures.
Zhenxing Sun
exaly   +6 more sources

Hemodynamics of Transcatheter Tricuspid Valve Replacement With Lux-Valve

Frontiers in Cardiovascular Medicine, 2022
ObjectiveTranscatheter tricuspid valve intervention (TTVI) has emerged as an alternative treatment option for high-risk and inoperable patients with symptomatic tricuspid regurgitation (TR). However, scarce data in hemodynamic profiles were available on TTVI.
Fanglin Lu, Bailing Li
exaly   +5 more sources

Transcatheter Tricuspid Valve Implantation With LuX-Valve Utilizing a Novel Patient-Specific Virtual and Physical Simulator: A Case Report [PDF]

European Heart Journal - Case Reports
Abstract Background The rise of transcatheter tricuspid valve implantation (TTVI) therapies represents a major advancement for high-risk patients with severe tricuspid valve regurgitation, offering a safer, minimally invasive alternative to open-heart surgery. However, the low volume of procedures and
Walid Ben Ali, Mohammed Nejjari, Julien Dreyfus   +2 more
exaly   +5 more sources

First-in-Man Experience of Transcatheter Tricuspid Valve Replacement With LuX-Valve in High-Risk Tricuspid Regurgitation Patients

JACC: Cardiovascular Interventions, 2020
Tricuspid valve regurgitation is one of the common valvular diseases ([1][1]). Severe tricuspid regurgitation (TR) is associated with a 5-year survival rate of 
Lin Han, An Zhao, Fan Qiao
exaly   +3 more sources

Step-by-Step Transcatheter Tricuspid Valve Replacement Using the LuX-Valve Plus System.

Case Reports
The LuX-Valve Plus is a novel radial force-independent orthotopic transjugular transcatheter tricuspid valve replacement device proven to be effective in TR reduction. We describe preprocedural assessment for eligibility and procedural planning by means of computed tomography as well as procedural steps of device implantation under multimodality ...
Kent CY So, Alex Pui-Wai Lee, Song Wan
exaly   +3 more sources

First Percutaneous Orthotopic Tricuspid Valve Implantations Using the LuX-Valve Plus Device in Latin America: Report of the First Three Cases

Arquivos Brasileiros De Cardiologia - Imagem Cardiovascular
Resumo Fundamento: A insuficiência tricúspide (IT) grave está associada a alta morbimortalidade, especialmente em pacientes com contraindicação cirúrgica. A substituição transcateter da valva tricúspide surgiu como alternativa minimamente invasiva para essa população, sendo o LuX-Valve Plus um dispositivo projetado para implantação ortotópica via ...
Marden Tebet, Vinicius Esteves
exaly   +3 more sources

Transcatheter Tricuspid Valve Replacement Using the LuX-Valve Plus System: 1-Year Compassionate Use Outcomes

European Journal of Heart Failure
Pedro A Villablanca, Edwin C Ho, Dhairya Patel   +2 more
exaly   +4 more sources

Antiseizure potency and neurotoxicity of the enantiomers of fenfluramine and norfenfluramine in rats and correlations with their concentrations in plasma and brain

Epilepsia, EarlyView.
Abstract Objective Based on the evidence that fenfluramine‐induced anorexia, weight loss, and cardiovascular toxicity are primarily mediated by the d‐enantiomers of fenfluramine and its metabolite norfenfluramine, we investigated pharmacokinetic/pharmacodynamic correlations for the active enantiomers of fenfluramine and norfenfluramine in the rat ...
Yara Sheeni, Dinorah Barasch, Tawfeeq Shekh‐Ahmad, Emilio Perucca, Meir Bialer   +4 more
wiley   +1 more source